These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 1928487

  • 21. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M, Horn E, Jones TT.
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. An open trial of buspirone in obsessive-compulsive disorder.
    Jenike MA, Baer L.
    Am J Psychiatry; 1988 Oct; 145(10):1285-6. PubMed ID: 3048120
    [Abstract] [Full Text] [Related]

  • 24. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr 22; 30(764):45-7. PubMed ID: 3258399
    [No Abstract] [Full Text] [Related]

  • 25. Neurologic soft signs in obsessive-compulsive disorder.
    Bihari K, Pato MT, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1991 Mar 22; 48(3):278-9. PubMed ID: 2036127
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fluoxetine treatment of obsessive-compulsive disorder.
    Turner SM, Jacob RG, Beidel DC, Himmelhoch J.
    J Clin Psychopharmacol; 1985 Aug 22; 5(4):207-12. PubMed ID: 3894437
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov 22; 31(6):1062-9. PubMed ID: 1429406
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Buspirone in ODD.
    Dunne JE.
    J Am Acad Child Adolesc Psychiatry; 1999 Aug 22; 38(8):942. PubMed ID: 10434482
    [No Abstract] [Full Text] [Related]

  • 33. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.
    Renshaw PF, Guimaraes AR, Fava M, Rosenbaum JF, Pearlman JD, Flood JG, Puopolo PR, Clancy K, Gonzalez RG.
    Am J Psychiatry; 1992 Nov 22; 149(11):1592-4. PubMed ID: 1415832
    [Abstract] [Full Text] [Related]

  • 34. Trazodone-fluoxetine combination for treatment of obsessive-compulsive disorder.
    Swerdlow NR, Andia AM.
    Am J Psychiatry; 1989 Dec 22; 146(12):1637. PubMed ID: 2589561
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M, Dugas M.
    Int Clin Psychopharmacol; 1993 Dec 22; 8(4):307-10. PubMed ID: 8277152
    [No Abstract] [Full Text] [Related]

  • 38. Use of fluoxetine for obsessive-compulsive behavior in adults with autism.
    Koshes RJ.
    Am J Psychiatry; 1997 Apr 22; 154(4):578. PubMed ID: 9090351
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.